Replies to post #499779 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Methylated Tumors were not an endpoint of the NWBO P3 trial. Hard to get any approval if you a.) don't design the trial for the proper data for approval, and then, b.) don't have a treatment and comparator arm to read the effect.

So how would it get approved?